Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Sep 2:3:22.
doi: 10.1186/1758-5996-3-22.

Low triglyceride levels are associated with a better metabolic control in patients with type 1 diabetes

Affiliations

Low triglyceride levels are associated with a better metabolic control in patients with type 1 diabetes

Leticia M Alcantara et al. Diabetol Metab Syndr. .

Abstract

Background: Although it is well known in the literature that high triglyceride serum (TG) levels can jeopardize the metabolic control, little is known about the influence of low TG on type 1 diabetes patients (T1D). The aim of this study is to investigate the distribution of TG serum levels in individuals with T1D and its relationship with metabolic control.

Findings: We reviewed the medical charts of 180 patients with T1D, who were classified in groups according to TG levels: 1) low (below 50 mg/dL); 2) normal (50-150 mg/dL); 3) high (above 150 mg/dL). TG were low in 21.1% (n = 38; group 1), normal in 68.6% (n = 123; group 2) and high in 10.6% (n = 19; group 3). High TG was associated with a poor metabolic control (p < 0.001). Patients with TG lower than 50 mg/dL had a lower HbA1c than those with TG between 50 and 150 mg/dL (7.41+/-1.50% vs 8.56%+/-1.94%; p = 0.002).

Conclusion: TG lower than 50 mg/dL was common and might be associated with a better metabolic control in patients with T1D, although it is not clear whether the former is the cause or consequence for the latter.

PubMed Disclaimer

Figures

Figure 1
Figure 1
HbA1c according to the groups with low, normal and high triglyceride. TGL: triglyceride level.

References

    1. Eisenbarth GS. Update in type 1 diabetes. J Clin Endocrinol Metab. 2007;92(7):2403–7. doi: 10.1210/jc.2007-0339. - DOI - PubMed
    1. Conway B, Miller RG, Costacou T, Fried L, Kelsey S, Evans RW. et al.Temporal patterns in overweight and obesity in Type 1 diabetes. Diabet Med. 2010;27(4):398–404. doi: 10.1111/j.1464-5491.2010.02956.x. - DOI - PMC - PubMed
    1. Berenson GS, Srinivasan SR, Bao W, Newman WP, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med. 1998;23(338):650–6. - PubMed
    1. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353(25):2643–53. - PMC - PubMed
    1. ACCORD Study Group. Gerstein HC, Miller ME, Genuth S, Ismail-Beigi F, Buse JB, Goff DC Jr. et al.Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med. 2008;358:2545. - PMC - PubMed

LinkOut - more resources